Device Trial Radar · NCT07256951
Gen 2 Battrode Wear Study
Last checked: Nov 20, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Nov 12, 2025
Primary completion
Dec 23, 2025
Study completion May 15, 2026
Sponsor
- Lead sponsor
- Baxter Healthcare CorporationPublic (BAX)
- Sponsor type
- Industry
- First posted
- Dec 1, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Validating adhesive wear time
Conditions
- Adhesive Wear Time
Interventions
AdhesiveDevice
14 day wear
Primary outcomes
What the sponsor says the trial is designed to measure.
- Wear timeTime frame: 15 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Orange County Research Center
Lake Forest, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.